Real-World Data Show Carfilzomib Regimens Deliver Strong Results in Multiple Myeloma
The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent effectiveness, and stable quality ...
The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent effectiveness, and stable quality ...
A cross-sectional study of 32 multiple myeloma patients found that talquetamab caused taste disturbances in every participant, with impaired taste ...
A SEER-Medicare analysis of 20,437 older adults found that 37 percent of multiple myeloma diagnoses occurred through emergency department involvement, ...
A real-world study of fifty multiple myeloma patients found that high-dose melphalan with autologous stem cell transplantation doubled complete response ...
A survey of 100 multiple myeloma patients in Germany finds that nearly half highly value treatment-free intervals for recovery, yet ...
The largest MGUS screening study in sub-Saharan Africa found that roughly 15 percent of Black South Africans in Soweto carry ...
A large real-world study of 812 Chinese multiple myeloma patients identified ten routine clinical parameters, including several long-overlooked blood measures, ...
A new first-person perspective in Advances in Therapy follows a music professor through repeated myeloma relapses to talquetamab therapy, revealing ...
A nationwide claims analysis found that most oral blood cancer drug prescriptions were initially rejected by insurers and that high ...
A German research team has validated time to subsequent therapy as a patient-relevant oncology endpoint and developed standardized checklists to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine